As of 2025-09-18, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (95.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.68 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -1202.7%.
The range of the Relative Valuation is (81.56) - (98.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.6x | 18.1x |
| Forward P/E multiples | 17.0x - 26.6x | 21.8x |
| Fair Price | (81.56) - (98.93) | (95.71) |
| Upside | -1039.6% - -1239.7% | -1202.7% |
| Date | P/E |
| 2025-07-30 | -1.81 |
| 2025-07-29 | -1.81 |
| 2025-07-28 | -1.83 |
| 2025-07-25 | -1.83 |
| 2025-07-24 | -1.83 |
| 2025-07-23 | -1.83 |
| 2025-07-22 | -1.82 |
| 2025-07-21 | -1.87 |
| 2025-07-18 | -1.90 |
| 2025-07-17 | -1.91 |
| 2025-07-16 | -1.90 |
| 2025-07-15 | -1.91 |
| 2025-07-14 | -1.91 |
| 2025-07-11 | -1.93 |
| 2025-07-10 | -1.92 |
| 2025-07-09 | -1.92 |
| 2025-07-08 | -1.91 |
| 2025-07-07 | -1.91 |
| 2025-07-03 | -1.92 |
| 2025-07-02 | -1.89 |
| 2025-07-01 | -1.89 |
| 2025-06-30 | -1.90 |
| 2025-06-27 | -1.91 |
| 2025-06-26 | -1.93 |
| 2025-06-25 | -1.93 |
| 2025-06-24 | -1.92 |
| 2025-06-23 | -1.94 |